- Home
- NTB vs IDYA Comparison
NTB vs IDYA Comparison
Compare NTB & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTB
- IDYA
- Stock Information
- Founded
- NTB 1858
- IDYA 2015
- Country
- NTB Bermuda
- IDYA United States
- Employees
- NTB N/A
- IDYA N/A
- Industry
- NTB Commercial Banks
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- NTB Finance
- IDYA Health Care
- Exchange
- NTB Nasdaq
- IDYA Nasdaq
- Market Cap
- NTB 1.9B
- IDYA 2.3B
- IPO Year
- NTB 2016
- IDYA 2019
- Fundamental
- Price
- NTB $45.17
- IDYA $24.53
- Analyst Decision
- NTB Buy
- IDYA Buy
- Analyst Count
- NTB 3
- IDYA 14
- Target Price
- NTB $51.33
- IDYA $47.75
- AVG Volume (30 Days)
- NTB 161.5K
- IDYA 1.2M
- Earning Date
- NTB 10-21-2025
- IDYA 11-03-2025
- Dividend Yield
- NTB 4.43%
- IDYA N/A
- EPS Growth
- NTB 14.60
- IDYA N/A
- EPS
- NTB 4.96
- IDYA N/A
- Revenue
- NTB $588,897,000.00
- IDYA $7,000,000.00
- Revenue This Year
- NTB $3.31
- IDYA $62.30
- Revenue Next Year
- NTB N/A
- IDYA $285.58
- P/E Ratio
- NTB $9.12
- IDYA N/A
- Revenue Growth
- NTB 2.95
- IDYA N/A
- 52 Week Low
- NTB $34.77
- IDYA $13.45
- 52 Week High
- NTB $46.89
- IDYA $37.80
- Technical
- Relative Strength Index (RSI)
- NTB 51.86
- IDYA 49.69
- Support Level
- NTB $44.50
- IDYA $23.23
- Resistance Level
- NTB $45.67
- IDYA $25.49
- Average True Range (ATR)
- NTB 0.82
- IDYA 1.34
- MACD
- NTB 0.05
- IDYA -0.15
- Stochastic Oscillator
- NTB 72.52
- IDYA 29.15
About NTB Bank of N.T. Butterfield & Son Limited (The) Voting
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, Cayman Islands, the Channel Islands and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.